Abstract
RNA interference (RNAi) is a conserved cellular mechanism in most eukaryotes that can mediate specific gene silencing. Since its discovery in 1998, rapid progress has been made in understanding its basic mechanism and its application in research and drug discovery. In recent years, the application of RNAi in research, including research in neurodegeneration, has expanded rapidly such that it has become a regular tool for reverse genetics in cultured cells in many labs. However, an incomplete understanding of the RNAi mechanism and worries about its pitfalls still intimidate many others. Here, we present a streamlined and simple protocol for the design and implementation of an RNAi experiment in cultured cells, aiming to enable those who are inexperienced with RNAi to apply this powerful method in their research, particularly in the field of neurodegeneration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mello, C. C., and Conte, D. (2004) Revealing the world of RNA interference. Nature. 431, 338–342.
Tomari, Y., and Zamore, P. D. (2005) Perspective: machines for RNAi. Genes Dev. 19, 517–529.
Xia, X., Zhou, H., Huang, Y., and Xu, Z. (2006) Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo. Neurobiol. Dis. 23, 578–586.
Qiu, L., Wang, H., Xia, X., Zhou, H., and Xu, Z. (2008) A construct with fluorescent indicators for conditional expression of miRNA. BMC Biotechnology. 8, 77.
Pei, Y., and Tuschl, T. (2006) On the art of identifying effective and specific siRNAs. Nat Meth. 3, 670–676.
Birmingham, A., Anderson, E., Sullivan, K., Reynolds, A., Boese, Q., Leake, D., Karpilow, J., and Khvorova, A. (2007) A protocol for designing siRNAs with high functionality and specificity. Nat. Protocols. 2, 2068–2078.
Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A., Manoharan, M., Akira, S., de Fougerolles, A., Endres, S., and Hartmann, G. (2005) Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11, 263–270. Epub 2005 Feb 2020.
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., and MacLachlan, I. (2005) Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotech. 23, 457–462.
Lan, T., Putta, M. R., Wang, D., Dai, M., Yu, D., Kandimalla, E. R., and Agrawal, S. (2009) Synthetic oligoribonucleotides-containing secondary structures act as agonists of Toll-like receptors 7 and 8. Biochemical and Biophysical Research Communications. 386, 443–448.
Borchert, G. M., Lanier, W., and Davidson, B. L. (2006) RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol. 13, 1097–1101.
Zhou, H., Xia, X. G., and Xu, Z. (2005) An RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAi. Nucl. Acids Res. 33, e62.
Cashman, N. R., Durham, H. D., Blusztajn, J. K., Oda, K., Tabira, T., Shaw, I. T., Dahrouge, S., and Antel, J. P. (1992) Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn. 194, 209–221.
Acknowledgments
This work has been supported by RO1 NS048145 and R21 NS062230-01.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Yang, C., Qiu, L., Xu, Z. (2011). Specific Gene Silencing Using RNAi in Cell Culture. In: Manfredi, G., Kawamata, H. (eds) Neurodegeneration. Methods in Molecular Biology, vol 793. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-328-8_30
Download citation
DOI: https://doi.org/10.1007/978-1-61779-328-8_30
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-327-1
Online ISBN: 978-1-61779-328-8
eBook Packages: Springer Protocols